Generic drug products are defined as?

Generic drug products are defined as?

• A. Not subject to FDA oversight.
• B. Drug products that are therapeutically equivalent to the brand-name product and contain the same amount of the drug substance in the same type of dosage form.
• C. Always more effective than brand-name.
• D. Contain different amounts of the drug substance.

Answer: (B)

The key idea is that generics are defined by therapeutic equivalence to the brand-name product and by delivering the same amount of the active drug in the same dosage form. For a generic to be approved, it must earn the FDA’s approval via an abbreviated pathway showing bioequivalence to the brand-name product. That means it has to reach the patient’s system in essentially the same rate and amount as the brand-name, so there’s no meaningful difference in safety or effectiveness. This requires the same active ingredient, the same strength (amount of drug), the same dosage form, and the same route of administration. Excipients can vary, but they must not change the product’s critical performance in a way that would alter bioavailability or therapeutic effect. Generics are still subject to FDA oversight and quality standards. They are not inherently more effective than brand-name products; they are expected to be therapeutically equivalent, not superior. Having different amounts of the drug substance would defeat the purpose of equivalence.

The key idea is that generics are defined by therapeutic equivalence to the brand-name product and by delivering the same amount of the active drug in the same dosage form. For a generic to be approved, it must earn the FDA’s approval via an abbreviated pathway showing bioequivalence to the brand-name product. That means it has to reach the patient’s system in essentially the same rate and amount as the brand-name, so there’s no meaningful difference in safety or effectiveness.

This requires the same active ingredient, the same strength (amount of drug), the same dosage form, and the same route of administration. Excipients can vary, but they must not change the product’s critical performance in a way that would alter bioavailability or therapeutic effect. Generics are still subject to FDA oversight and quality standards. They are not inherently more effective than brand-name products; they are expected to be therapeutically equivalent, not superior. Having different amounts of the drug substance would defeat the purpose of equivalence.